Skip to main content
Premium Trial:

Request an Annual Quote

GenoSplice, Institut Curie Partner on Cancer Genomics

NEW YORK (GenomeWeb News) – Bioinformatics firm GenoSplice Technology and Institut Curie's Curie-Cancer today said they are collaborating in the area of cancer genomics.

GenoSplice will have access to several Curie-Cancer technology platforms and be included in Institut Curie research programs. In addition to contributing to the development of new oncology products, the collaboration will result in a better understanding of complex diseases through genome mapping, the partners said.

GenoSplice will use Curie-Cancer's genomic technology to offer data processing to its clients in the pharmaceutical space, biotechnology laboratories, and academic research centers.

One project stemming from its collaboration with Curie-Cancer — which is responsible for developing partnerships for Institut Curie — is aimed at defining a genomic map for prostate cancer. The map will be based on data from several hundred patients with the disease with the goal of elucidating the mechanisms involved in prostate cancer and stratifying patients so that physicians can make more informed treatment decisions.

Another project will be directed at a new cell-penetrating peptide molecule. Specifically, the project seeks to identify biomarkers that can help determine which patients may be best responders to the molecule.

In a statement, Pierre de la Grange, scientific director and co-founder of GenoSplice, said, "Participating in research projects with the Institut Curie, which are sometimes multi-party and involve other international research institutes, will put us at the forefront of developments in our areas of interest and will enable us to provide the best possible service to our clients."

GenoSplice is based in Paris and develops services for the analysis of genomic data obtained from sequencing and DNA microarrays.

The partners did not disclose financial and other terms of the deal.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.